While SMB is a ling maw contract and not the neutraceutical where the growth will be, it was a solid revenue foundation while that side of the business ramps up. The contract was also a big reason as to why this stock flew off the handle from 1c. This may soften our upcoming quarterly significantly, so I'm not expecting much upwards movement this month (unless a positive ANN). Without this cashflow supporting the business, I believe this has made the stock alot more speculative than it was.
However the money isn't in ling maw long term and I'm hoping long term this is just a hiccup. I'm in accumulation mode now. I'll pick my parcels and back Aldo and the team because I believe in the neutraceutical side of business and believe they are in a position post-CR to deliver in spades.
Disclosure: I've been in since a cent and have taken a lot of profits. I no longer have the large position I had but see a possible opportunity to change that.
- Forums
- ASX - By Stock
- Ann: Trading Halt
While SMB is a ling maw contract and not the neutraceutical...
Featured News
Add NZS (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.334M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
NZS (ASX) Chart |
Day chart unavailable